LBA12 Datopotamab deruxtecan (Dato-DXd) vs docetaxel in previously treated advanced/metastatic (adv/met) non-small cell lung cancer (NSCLC): Results of the randomized phase III study TROPION-Lung01

作者：M-J. Ahn, Aaron Lisberg, Luis Paz‐Ares, Robin Cornelissen, Nicolas Girard, Elvire Pons‐Tostivint, David Vicente Baz, Shunichi Sugawara, Manuel Cobo, M. Pérol, Céline Mascaux, Elena Poddubskaya, Satoru Kitazono, Hidetoshi Hayashi, Jacob Sands, Richard D. Hall, Yong Zhang, H. Zebger-Gong, Deise Uema, Isamu Okamoto · 发表于：Annals of Oncology · 年份：2023 · DOI：10.1016/j.annonc.2023.10.061 · 被引用次数：56 · 研究领域：Lung Cancer Treatments and Mutations、HER2/EGFR in Cancer Research、Monoclonal and Polyclonal Antibodies Research